HSP90AA1 antibody (AA 380-732)
Quick Overview for HSP90AA1 antibody (AA 380-732) (ABIN7114903)
Target
See all HSP90AA1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 380-732
-
Purpose
- HSP90AA1 antibody
-
Purification
- Protein A+G purification
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
-
Immunogen sequence: 380-732aa
Immunogen: heat shock protein 90kDa alpha(cytosolic), class A member 1
-
Isotype
- IgG1
-
-
-
-
Application Notes
- WB: 1:1000-1:8000, IHC: 1:50-1:500
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months
-
Expiry Date
- 12 months
-
-
- HSP90AA1 (Heat Shock Protein 90kDa alpha (Cytosolic), Class A Member 1 (HSP90AA1))
-
Alternative Name
- HSP90AA1
-
Background
-
Synonyms: Heat shock protein HSP 90-alpha|Heat shock 86 kDa (HSP 86, HSP86)|Lipopolysaccharide-associated protein 2 (LAP-2, LPS-associated protein 2)|Renal carcinoma antigen NY-REN-38|HSP90AA1|HSP90A|HSPC1|HSPCA
Background: HSP90, encoded by HSP90AA1, is a constitutively and ubiquitously expressed molecular chaperone that is crucial for the stability and function of many proteins. HSP90 provides chaperoning activity for client proteins, many of them are members of oncogenic pathways, indicating its implication in tumor malignancy. HSP90 mainly resides in the cytosol, while it can also be released to the extracellular space. Secreted Hsp90 is a C-terminal truncated form. It has been reported that the level of plasma Hsp90 is positively correlated with tumor malignancy in clinical cancer patients, and can be a promising diagnostic marker for tumor malignancy in clinical application.
-
Molecular Weight
- 90 kDa
-
Gene ID
- 3320
-
UniProt
- P07900
-
Pathways
- M Phase, Regulation of Cell Size, Signaling Events mediated by VEGFR1 and VEGFR2, VEGFR1 Specific Signals
Target
-